AJMC Staff

President to sign travel ban meant to contain more contagious variants of coronavirus disease 2019 (COVID-19); limited vaccine supply concerns top health officials; Merck ends COVID-19 vaccine development.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

The FDA approved the first injectable monthly treatment for HIV; Eli Lilly announced positive effects of its monoclonal antibody treatment for coronavirus disease 2019 (COVID-19); President Joe Biden will sign an executive order on food insecurity.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

New research shows Pfizer/BioNTech's vaccine is effective against the B.1.1.7. variant of coronavirus disease 2019 (COVID-19); Amazon offers to aid vaccine distribution; FDA issues drug safety labeling changes for Enhertu.

Elderly individuals have started to withdraw from Novovax’s coronavirus disease 2019 (COVID-19) vaccine trial; California reports possible allergic reactions to the Moderna COVID-19 vaccine; LGBTQ individuals increasingly report being refused health care treatment.

In California, a novel variant of coronavirus disease 2019 (COVID-19) may be less susceptible to approved vaccines; COVID-19 vaccine trials are assessing efficacy in adolescents; HHS relaxes a regulation on prescribing addiction medication.

Vaccination rates against coronavirus disease 2019 (COVID-19) are significantly lower in Black Americans compared with White Americans; spotlighting the impact of the pandemic on children with mental illness; a rapid blood test predicts which patients with COVID-19 are at highest risk of severe complications or death.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Lumasiran works by inhibiting the production of oxalate.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

HHS aims to ease access to medication-assisted treatment for patients with opioid use disorder; David Kessler, MD, named top Operation Warp Speed official; President-Elect Joe Biden unveils coronavirus disease 2019 (COVID-19) relief package.

Former Michigan Governor Rick Snyder is charged over his role in the Flint water crisis of 2014; states report new strains of coronavirus disease 2019 (COVID-19); the United States could see 90,000 more COVID-19 deaths in 3 weeks.

The Supreme Court reinstates the requirement on in-person pickup of pregnancy-ending medications; CMS releases numbers on 2020’s final week of Marketplace open enrollment; the FDA updates safety information for filgrastim (Neupogen).

FDA accepts for priority review a Biologics License Application for V114, Merck's investigational 15-valent pneumococcal conjugate vaccine; bluebird bio will be split into 2 publicly traded drug companies; a new variant of coronavirus is reported in Japan.

The incoming Biden administration announces plans to rapidly release most available vaccine doses against coronavirus disease 2019; the Trump administration approves the first Medicaid block grant in Tennessee; pharmaceutical executives and trade groups condemn last week’s pro-Trump riots on Capitol Hill.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

A recent study sought to examine the course of these patients after the age of 40, and to identify possible risk factors for a worse prognosis.

A recent study evaluated the content validity of patient-reported outcome instruments used in low-risk myelodysplastic syndrome (MDS).

A study links the size of cysts associated with endometriosis with coexistent ovarian cancer.

The American Hospital Association (AHA) asks HHS Secretary Alex Azar to expedite the rollout of coronavirus disease 2019 vaccines; CDC data show accelerated cardiac aging among cancer survivors; a study examines new targets for reducing adolescent access to opioids.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A Democratic majority in the United States Senate could mean changes in health care policy are to come; CDC says benefits of the coronavirus disease 2019 (COVID-19) vaccine outweigh risks of allergic reactions; Los Angeles faces a shortage of oxygen.

The coronavirus disease 2019 (COVID-19) pandemic disrupted many mental health services for children; a study on the long-term effects of COVID-19 will soon kick off; a $13-billion deal has been struck for UnitedHealth to buy Change Healthcare.

The FDA warns against making any changes to the authorized dosing schedules of coronavirus disease 2019 (COVID-19) vaccines; joint health care venture, Haven, dissolves; Moderna announced it will increase production of its vaccine by 100 million doses for 2021.

Discussions between the FDA and Operation Warp Speed officials have mentioned the implementation of half-dose coronavirus disease 2019 vaccine regimens; the United Kingdom becomes the first country to administer the AstraZeneca/Oxford vaccine; the outlook for mental health in 2021.

A new study from Sweden cautions against routine discontinuation of renin-angiotensin system (RAS) inhibitors in patients with chronic kidney disease (CKD).

Previous studies have shown conflicting characteristic thermographic patterns of the feet in patients with active rheumatoid arthritis (RA). This study probed whether the thermal characteristics of the feet of patients in remission differ to those of healthy controls.

Previous studies have suggested that inflammatory diseases such as rheumatoid arthritis (RA) can increase the risk for dementia and that tumor necrosis factor agents may have a role in preventing the incidence of dementia.

Usually, macrophages protect the lungs from attacks. But under certain conditions, lung macrophages can also contribute to severe lung diseases, like chronic obstructive pulmonary disease, or worsen coronavirus disease 2019 (COVID-19).